Having trouble viewing this email? View in your browser.

27 June 2021

Dear colleagues,

Please find below the latest edition of ESCMID Industry News.

With kind regards,
ESCMID Executive Office.

logo company 1 logo company 2 logo company 3
Image company 1 Image company 2 Image company 3

Thermo Fisher

Thermo Fisher Scientific is the leading single-source supplier for SARS-CoV-2 testing needs, with involvement in more than 50% of worldwide testing.

Join us on 9 July where scientific experts will share their latest results on SARS-CoV-2 detection and how their labs implemented the TaqMan® SARS-CoV-2 Mutation Panel for mutation confirmation.

Discover our solutions for SARS-CoV-2 isolation, detection, mutation conformation, and surveillance.


We at Pfizer are proud to support the 31st meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). We are sponsoring six virtual symposia dedicated to the treatment of infectious diseases, the role of patients in infectious disease research and key learnings from COVID-19 adversity.

For more information about Pfizer’s commitment to infectious disease research, please visit our website.


For a unique and immersive experience to find out more about Pfizer, remember to create your own avatar and take a look around the Pfizer Space Lab!

Here, our virtual booth contains a number of vaults for you to discover more about Pfizer’s commitment to developing medicines for much needed therapies. Plus you can test your knowledge with Pfizer’s interactive timeline game. To discover more, access the Pfizer Space Lab launching July 8th 2021.

› For more information › For more information › For more information

Date of preparation: June 2021

Date of preparation: June 2021

ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.